According to the 2015 China Pharmaceutical Industry Analysis Report, since the reform and opening up, China's pharmaceutical industry has developed rapidly, even surpassing the average development rate of major pharmaceutical countries in developed countries in the past 30 years. In the future, the important characteristic of China's pharmaceutical industry will be the separation of chemical drugs, natural drugs (traditional Chinese medicine), and biopharmaceuticals. The natural medicine (traditional Chinese medicine) in China mainly has three forms: Chinese medicinal materials, plant extracts and traditional Chinese patent medicines and simple preparations. Among them, the proportion of plant extracts located in the middle reaches has significantly increased in recent years, and the market prospects are promising.

The author understands that many plant extract manufacturers in China export their products to Asia, North America, and Europe. In addition, with the pursuit of natural and healthy living concepts in recent years, and Tu Youyou winning the Nobel Prize in Physiology or Medicine in 2015, China's traditional Chinese medicine market is vast.

But while seeing development opportunities, we should also recognize the shortcomings of the current plant extract industry. It is understood that currently, the production and operation of plant extract manufacturers in China are scattered, mainly small and medium-sized enterprises, and the manufacturing process is not yet mature enough.

The head of a pharmaceutical company stated that compared to the domestic market, the entry threshold for foreign markets is becoming higher and higher. Most EU enterprises refer to the European Pharmacopoeia, and their standardized classification is already very detailed. They are divided into quantified extracts, standard extracts, and purified extracts d on their intrinsic quality. Further normative discussions are still underway, and the customer requirements in domestic and foreign markets are also increasing, which has prompted the plant extract industry to improve product quality and comply with market development trends.

The road to future development is long and arduous

Experts say that advanced processes (such as enzymatic extraction, ultrasonic extraction, supercritical extraction, microwave extraction, membrane separation technology, etc.) and quality detection technologies (meteorological, liquid phase, heavy l residue, microbial detection) are required for the extraction process of plant extracts. These devices fully reflect the requirements of modernization of traditional Chinese medicine and are also a breakthrough point for the advancement of the plant extract industry.

Overall, the plant extract industry is a technology dependent industry. Advanced extraction processes and equipment can not only significantly improve the quality of extract products, but also improve the utilization rate of raw materials, reduce raw material waste, and reduce production costs. With the increasing number of industry competitors and the increasing intensity of competition, enterprises will inevitably choose the development strategy of continuously improving technology and developing new processes.

Summary: Whether it is for pet disinfectants or other products, the future development of the plant extract industry is a long and arduous journey. Pharmaceutical companies need to increase their research and development efforts, improve their technological level, optimize production processes, configure automation equipment, and process high-quality product materials to develop more scientific, reasonable, and effective products that meet different consumer needs, refine management, and achieve better service.